Researcher Stories
Get to know the PhRMA Foundation’s award recipients.
Developing a Platform for Personalized Cancer Vaccines
Xinyi Tu, a PhD student at Arizona State University, is developing a cancer vaccine platform that uses nanoparticles to deliver vaccine ingredients to the immune system.
Watch Now
Using Digital Health Tools and AI to Improve Outcomes for Patients with Irregular Heartbeat
Dr. Nino Isakadze is conducting a clinical trial examining whether using digital health tools can help patients make lifestyle modifications to improve outcomes for atrial fibrillation (Afib), an irregular heartbeat.
Read More
Investigating the Role of a Common Human Virus in Brain Tumors
Brown University PhD student Noe Mercado is studying the role of human cytomegalovirus in glioblastoma, fast-growing, aggressive brain tumors.
Watch NowA New Approach to Treating Fatty Liver Disease
Sergei Kutseikin, a PhD student at Scripps Research Institute, is researching new treatments for fatty liver disease, a condition where fat builds up in the liver, leading to inflammation, liver cell damage, and liver scarring.
Awardee Spotlight
Ariel Leyte-Vidal
- University of Miami
“I am profoundly honored to receive the PhRMA Foundation fellowship, which acknowledges my efforts in hematology research and strengthens my commitment to advancing patient care. With the support of this grant, I aim to uncover a novel mechanism of resistance to kinase inhibitor treatment for chronic myeloid leukemia (CML), which will advance the understanding of kinase cancer biology and establish a model for elucidating mechanisms of resistance to an emerging class of allosteric molecular targeted cancer therapies. Importantly, my findings will help patients avoid ineffective and unnecessary delay in access to treatment.”
Advancing Precision Genome Editing Therapies for Rare Diseases
Dr. Samagya Banskota of Boston University is developing precision genome editing therapeutics that allow scientists to both understand the mutations that cause genetic diseases and develop therapeutic strategies to treat them.